Oncology Perspective

• Did an Unfair System Help ADAURA Win on Overall Survival? Jack West, MD, discusses the problematic design and ethical issues of the ADAURA trial.
  Medscape Oncology, June 08, 2023
• High Hopes, Dashed Dreams: Progress in GI Cancers at ASCO   Mark A. Lewis, MD, discusses news in GI oncology from the 2023 ASCO Annual Meeting.
  Medscape Oncology, June 08, 2023
• Tragedy, Hope, and a Medical Mystery: 'The Covenant of Water'   Dr Eric Topol and Dr Robert Harrington interview Dr Abraham Verghese about his fiction writing methods and Oprah's enthusiasm for his latest novel.
  Medscape, June 07, 2023
• Episode 3: Immunotherapy in Advanced and Metastatic Breast Cancer   Drs Banu Arun and Kevin Kalinsky discuss immunotherapy in the treatment of advanced and metastatic breast cancer, including recent studies, side effects, access to treatment, and disparities in care.
  Medscape, June 07, 2023
• NSCLC e-Tumor Boards: Case 6: NSCLC with Multiple Primaries   This case is about a 75-year-old woman with poor performance status with multiple primary lung cancers, the highest stage being IIIA-N2, with multiple recurrences after various local therapy modalities since 2006. The team highlights the power of pathology and the value of molecular diagnostics in distinguishing between the lesions.
  Medscape, June 06, 2023
• S2 Episode 3: Renal Medullary Carcinoma   Drs Sumanta Pal and Pavlos Msaouel discuss the unique pathophysiology of renal medullary carcinoma, treatment options, clinical trials, and the importance of screening and early detection.
  Medscape, June 06, 2023
• Transplant Centers Often Skip the Top Spot on the Kidney Waitlist   How donor kidneys are allocated to waiting patients isn't as straightforward as it might seem.
  Medscape, June 05, 2023
• Medscape Physician Assistant Compensation Report 2023 Physician assistants (PAs) seem increasingly dissatisfied with their compensation, even though it rose last year. Gender and age made a difference, with male and older PAs earning more on average.
  Medscape Features Slideshows, June 02, 2023
• What's Wrong With Cancer Clinical Trials? Look at Olaparib Oncologist Bishal Gyawali, MD, PhD, discusses problematic reporting of olaparib trials.
  Medscape Oncology, June 01, 2023
• Episode 2: Quality of Survival: Colorectal Cancer in Older Adults   When you see an older adult with colorectal cancer, how do you fit your care to their needs? Join Dr Benjamin Schlechter and geriatric medical oncology expert Dr Nadine McCleary for clinical pearls.
  Medscape, June 01, 2023
• Episode 1: When Should You Consider Immunotherapy in Colorectal Cancer?   Keep up to date on the newest research and clinical application of immunotherapy treatments in colorectal cancer with leading experts Drs Benjamin Schlechter and Marwan Fakih.
  Medscape, June 01, 2023
• The Upside of Rejection Jack West, MD, discusses how rejection can be challenging but often makes us better.
  Medscape Oncology, May 31, 2023
• Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma   Drs Peter Martin and Anita Kumar discuss covalent and noncovalent Bruton tyrosine kinase (BTK) inhibitors in the frontline setting, BTK mutations, and the complicated mechanisms of resistance.
  Medscape, May 31, 2023
• COVID Boosters Effective, but Not for Long   Dr F. Perry Wilson explains a unique study design that helps answer questions about the effectiveness of COVID booster vaccines.
  Medscape, May 30, 2023
• Racial Disparities in CLL: Underrepresentation in Clinical Trials   Joanna Rhodes, MD, MSCE observes differences in the disease biology of chronic lymphocytic leukemia in younger Black patients and emphasizes the need for enrolling non-White patients in clinical trials and ongoing research.
  Medscape, May 30, 2023
• A Path to a Career in CLL Clinical Research   Joanna Rhodes, MD, MSCE, narrates a change in focus from acute leukemias and bone marrow transplants to the field of chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• Improving Quality of Life in Patients With CLL: Managing Side Effects From Targeted Therapy   Joanna Rhodes, MD, MSCE, reflects on a patient who experienced side effects from targeted agents for chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• The Costs of Disparities in the Treatment of Chronic Lymphocytic Leukemia   Seema Bhat, MD, reflects on the inequities of access to treatment and deficiencies in research for chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia   Seema Bhat, MD, comments on the character of collaboration in the development of therapies for chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• Learning to Appreciate the Impact of CLL on the Lives of Patients   Kerry Rogers, MD, reflects on what she underestimated about CLL when she first started seeing patients as a fellow.
  Medscape, May 30, 2023